ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRX Amneal Pharmaceuticals Holding Co

5.87
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High

Low
2.29

52 Week Range

High
5.95

Day Low
Share Name Share Symbol Market Stock Type
Amneal Pharmaceuticals Holding Co AMRX NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 5.87 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.87 5.87
Trades Shares Traded Average Volume 52 Week Range
0 0 - 2.29 - 5.95
Last Trade Type Quantity Price Currency
- 0 US$ 5.87 USD

Amneal Pharmaceuticals Holding Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.8B 307.01M - 2.41B -83.99M -0.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amneal Pharmaceuticals News

Date Time Source News Article
6/05/202407:00Business WireAmneal Expands Broad Injectables Portfolio to Over 40..
5/22/202415:05Business WireAmneal to Participate at Upcoming Investor Conference
5/16/202414:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/14/202415:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/14/202415:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/14/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/14/202415:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:18Edgar (US Regulatory)Form 8-K - Current report
5/06/202416:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMRX Message Board. Create One! See More Posts on AMRX Message Board See More Message Board Posts

Historical AMRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months4.745.954.745.371,730,7971.1323.84%
1 Year2.645.952.293.991,266,6653.23122.35%
3 Years5.966.021.243.521,002,971-0.09-1.51%
5 Years7.317.481.244.031,343,872-1.44-19.70%

Amneal Pharmaceuticals Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Your Recent History

Delayed Upgrade Clock